Coya Therapeutics, Inc. (COYA) Misses Q2 EPS by 49c

Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q2 EPS of ($0.36), $0.49 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $163.62 thousand.

For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.

You May Also Be Interested In

• TikTok owner ByteDance said to secure $29.6bn loan for AI push
• Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
• Concrete Pumping Holdings (BBCP) Tops Q3 EPS by 1c